<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The patient was an elderly male who had radical surgery for <z:e sem="disease" ids="C0751498" disease_type="Neoplastic Process" abbrv="">sigmoid cancer</z:e> in 2001 </plain></SENT>
<SENT sid="1" pm="."><plain>Owing to <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of his <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> to the left supraclavicular lymph nodes in 2002, the patient was admitted to our hospital for systemic chemotherapy </plain></SENT>
<SENT sid="2" pm="."><plain>We started treatment with irinotecan, leucovorin, <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> (IFL) </plain></SENT>
<SENT sid="3" pm="."><plain>After administering 100 mg/m2 of irinotecan, 250 mg/m2 leucovorin and 600 mg/m2 <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> to the patient on day 1, grade 3 <z:hpo ids='HP_0001882'>leukopenia</z:hpo> developed rapidly and grade 4 <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> was observed on day 5 </plain></SENT>
<SENT sid="4" pm="."><plain>We excluded irinotecan from the medication and continued the administration of <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> and leucovorin, but his <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> had not been reduced sufficiently </plain></SENT>
<SENT sid="5" pm="."><plain>Based on some examination results, we assumed that the patient had <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> and that the severe side effects that occurred were due to prolongation of SN38 metabolism </plain></SENT>
<SENT sid="6" pm="."><plain>We again administered irinotecan but at reduced dose (25 mg/m2) </plain></SENT>
<SENT sid="7" pm="."><plain>Four courses of this modified IFL were administered safely and the response was favorable </plain></SENT>
</text></document>